Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroblastoma × Hematologic Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 8 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neoplasms 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Motor Activity 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Colonic Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Uveal Melanoma 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Opioid-Related Disorders 1 Neuroblastoma 1 Neoplastic Cells, Circulating 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Inflammation 1 Hodgkin Disease 1 Hepatic Veno-Occlusive Disease 1 HPV Positive Oropharyngeal Squamous Cell Carcinoma 1 Fibrosis 1

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 Cisplatin 28 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 Granulocyte Colony-Stimulating Factor 26 dinutuximab 25 3-Iodobenzylguanidine 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 humanized 3F8 anti-GD2 monoclonal antibody 14 naxitamab 13 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡